Parenteral Nutrition Market Summary

The global parenteral nutrition market size was estimated at USD 7.11 billion in 2023 and is projected to reach USD 10.68 billion by 2030, growing at a CAGR of 6.01% from 2024 to 2030. Development of technically advanced parenteral nutrition (PN) products with barcode assistance, growing preference for PN over enteral nutrition in COVID-19 patients, shorter hospital stays, and the reduced risk of infection are some of the factors boosting the product demand, thereby driving the market growth. Increasing prevalence of chronic diseases and malnutrition cases worldwide further contributes to the need for safe and efficient nutritional support solutions.

According to the ASPEN20 Virtual Conference, providing appropriate nutrition to adults with COVID-19 remained a priority for optimizing outcomes. This included overcoming various challenges amid the pandemic, such as a shortage of PN products due to a disrupted supply chain. The experience highlighted the importance of reliable nutrition therapy and encouraged healthcare facilities to focus on advanced PN formulations and stronger supply channels.

Key Market Trends & Insights

  • The North America parenteral nutrition market dominated the global industry with a 41.5% share in 2023. The region benefits from improved healthcare infrastructure, high diagnosis rates of nutritional deficiencies, and strong adoption of modern parenteral therapies.
  • The parenteral nutrition market in the U.S. is expected to grow at a CAGR of 5.92% over the forecast period due to the increasing number of patients requiring long-term nutritional support, a higher incidence of cancer and gastrointestinal disorders, and growing emphasis on personalized therapy based on specific nutritional needs.
  • By nutrient type, the single-dose amino acid solution segment accounted for the largest market share of 30.7% in 2023. This growth is supported by high usage in both acute and chronic patient populations for rebuilding muscle mass and improving metabolic function.
  • By stage type, the adult segment held the largest market share of 87.1% in 2023 owing to a rising population of older adults who are more prone to chronic illnesses requiring clinical nutrition support.
  • By indication type, the cancer segment dominated the market with a share of 17.6% in 2023. Many cancer patients suffer from malnutrition due to treatment side effects, making PN essential for sustaining energy, immunity, and treatment tolerance.

Order a free sample PDF of the Parenteral Nutrition Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

  • 2023 Market Size: USD 7.11 Billion
  • 2030 Projected Market Size: USD 10.68 Billion
  • CAGR (2024-2030): 6.01%
  • Europe: Largest market in 2023

Key Companies & Market Share Insights

Key players are adopting new product development, partnership, and merger & acquisition strategies to increase their market share. Notable players in the parenteral nutrition market include Baxter, Grifols, S.A., Allergan, Otsuka Pharmaceutical Factory, Inc., Actavis Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Vifor Pharma, Sichuan Kelun Pharmaceutical Co., Ltd., and Pfizer Inc. (Hospira Inc.). The development of new drugs by these companies and their entry into untapped markets to expand their reach are anticipated to further stimulate market growth.

Key Players

  • Baxter
  • Allergan
  • Otsuka Pharmaceutical Factory, Inc.
  • Grifols, S.A.
  • Braun Melsungen AG
  • Vifor Pharma
  • Fresenius Kabi AG
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Pfizer Inc. (Hospira Inc.)

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The parenteral nutrition market is set for steady growth due to rising malnutrition rates, increasing hospitalization, and ongoing demand for advanced clinical nutrition therapies. The growing burden of chronic diseases such as cancer and gastrointestinal disorders strengthens the need for PN solutions that support recovery and improve patient health outcomes. Advancements in sterile packaging, formulation quality, and automated delivery systems are enhancing treatment safety and efficiency. North America continues to lead due to strong healthcare capabilities, while emerging regions are expanding access to nutritional care. As healthcare providers prioritize patient-centric nutrition strategies, the market is expected to continue evolving and expanding globally.